What is the recommended management for gestational hypothyroidism, including levothyroxine dosing based on pre‑pregnancy weight, target TSH levels for each trimester, monitoring frequency, iodine supplementation, and postpartum dose adjustment?

Management of Gestational Hypothyroidism

Treat gestational hypothyroidism immediately with levothyroxine, targeting TSH <2.5 mIU/L in the first trimester and <3.0 mIU/L in the second and third trimesters, with monitoring every 4-6 weeks until stable. 1

Levothyroxine Dosing Strategy

For Pre-existing Hypothyroidism

• Preconception optimization: Adjust levothyroxine dose before pregnancy to achieve TSH ≤2.5 mIU/L 1
• Immediate pregnancy adjustment: Upon confirmation of pregnancy, increase levothyroxine dose by 30% (typically two additional tablets per week—nine tablets weekly instead of seven) 1
• Expected dose increase: Most women require 30% or more increase in dosage by 4-6 weeks gestation 1

For New-Onset Hypothyroidism During Pregnancy

Overt hypothyroidism (TSH ≥10 mIU/L):

• Start levothyroxine at 1.6 mcg/kg/day based on pre-pregnancy weight 2
• Recent evidence supports starting doses of 100-150 mcg daily for rapid normalization 3

Subclinical hypothyroidism (TSH 2.5-10 mIU/L):

• Start levothyroxine at 1.0 mcg/kg/day based on pre-pregnancy weight 2
• Alternative: Fixed dose of 50 mcg/day or more 1
• Weight-based dosing shows superior outcomes: After adjusting for confounders, weight-based dosing achieved 4.26 times greater odds of reaching target TSH within 4-8 weeks compared to fixed dosing 4

Important caveat: Nontablet levothyroxine formulations (liquid, soft gel) may require lower doses than tablets to achieve the same TSH target—approximately 1.5 mcg/kg/day versus 2.4 mcg/kg/day for tablets in non-post-thyroidectomy hypothyroidism 5

Target TSH Levels by Trimester

Trimester-specific targets 1:

• First trimester: TSH <2.5 mIU/L
• Second trimester: TSH <3.0 mIU/L
• Third trimester: TSH <3.0 mIU/L

These targets are based on high-quality evidence (USPSTF Level A) showing that overt hypothyroidism causes serious adverse fetal effects including impaired neurodevelopment, preterm birth, low birth weight, and increased fetal loss 1

Monitoring Frequency

During pregnancy 1:

• Check TSH within 30-40 days after any dose adjustment
• Once stable, monitor every 4-6 weeks throughout pregnancy
• For women with thyroid autoimmunity who are initially euthyroid, monitor every 4-6 weeks as they are at high risk for developing hypothyroidism 1

Critical timing consideration: TSH elevations can appear as early as 4-8 weeks gestation or as late as the third trimester, necessitating consistent monitoring 6

Iodine Supplementation

The evidence does not provide specific recommendations for routine iodine supplementation in the context of hypothyroidism management during pregnancy from the primary guideline sources. However, recent research suggests:

• Mild-to-moderate iodine deficiency (median UIC 94 μg/L) is associated with altered thyroid function 7
• Initiating iodine-containing supplements prepregnancy and continuing through pregnancy was associated with lower TSH and higher fT3/fT4 concentrations, suggesting improved thyroid function 7
• There is a U-shaped relationship between iodine intake and thyroid outcomes—both deficiency and excess adversely affect maternal thyroid function 8

Practical approach: Consider iodine status assessment in areas of known deficiency, but avoid excessive supplementation given the narrow optimal intake window.

Postpartum Dose Adjustment

Immediately after delivery: Reduce levothyroxine to the pre-pregnancy dose 1

Postpartum monitoring: Check TSH at 4-8 weeks postpartum to confirm appropriate dosing 2

This recommendation is based on high-quality evidence (USPSTF Level A, Grade 1 QQQQ) showing that most hypothyroid women require dose reduction after pregnancy 1

Common Pitfalls to Avoid

1. Delayed dose adjustment: Waiting for TSH confirmation before increasing levothyroxine in known hypothyroid women who become pregnant—the 30% empirical increase should occur immediately upon pregnancy confirmation 1

2. Inadequate initial dosing: Starting with doses too low (e.g., 25-50 mcg) in overt hypothyroidism when rapid normalization is critical—consider 100-150 mcg daily for new-onset overt hypothyroidism 3

3. Infrequent monitoring: Checking TSH less often than every 4-6 weeks risks prolonged periods of inadequate treatment during critical fetal neurodevelopment windows 1

4. Using non-pregnancy TSH targets: Applying the standard non-pregnant TSH range (0.4-4.0 mIU/L) instead of the stricter pregnancy-specific targets 1

5. Forgetting postpartum adjustment: Continuing the increased pregnancy dose postpartum can lead to iatrogenic hyperthyroidism 1